Corticosteroid, Cyclophosphamide, Cytarabine, Doxorubicin, Etoposide, Methotrexate, Rituximab, and Vincristine
About
Membership operator: AND
Therapies: 8
Therapies
Corticosteroid (tx:ncit:C2322)
Cyclophosphamide (tx:ncit:C405)
Cytarabine (tx:ncit:C408)
Doxorubicin (tx:ncit:C456)
Etoposide (tx:ncit:C491)
Methotrexate (tx:ncit:C642)
Rituximab (tx:ncit:C1702)
Vincristine (tx:ncit:C933)
Therapeutic response
Precision oncology relationships for therapeutic response involving this therapy group.
Organizations
Biomarkers
Cancer types
Therapies
| Organizations | Biomarkers | Cancer types | Therapies | |
|---|---|---|---|---|
| EMA (1) | CD20 + | Diffuse Large B-Cell Lymphoma | Corticosteroid, Cyclophosphamide, Cytarabine, Doxorubicin, Etoposide, Methotrexate, Rituximab, Vincristine | |
| EMA (1) | CD20 + | Non-Hodgkin Lymphoma | Corticosteroid, Cyclophosphamide, Cytarabine, Doxorubicin, Etoposide, Methotrexate, Rituximab, Vincristine | |
| EMA (1) | CD20 + | Burkitt Lymphoma | Corticosteroid, Cyclophosphamide, Cytarabine, Doxorubicin, Etoposide, Methotrexate, Rituximab, Vincristine |